The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Genome-Wide Association Studies Market In 2026 And 2030?
The genome-wide association studies market size has experienced swift expansion in recent years. It is projected to grow from $2.27 billion in 2025 to $2.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.7%. Historically, this growth has been driven by the expansion of genetic research initiatives, increasing availability of genomic datasets, growth in academic population studies, rising adoption of genotyping technologies, and improvements in data analysis capabilities.
The market size for genome-wide association studies is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $4.26 billion, exhibiting a compound annual growth rate (CAGR) of 13.4%. This anticipated growth during the forecast period is fueled by several factors, including the escalating demand for precision medicine insights, increasing investments in genomic analytics platforms, the expansion of AI-driven genetic research, a growing pharmaceutical interest in target discovery, and an increasing emphasis on predictive healthcare models. Key trends expected within the forecast period encompass a greater adoption of large-scale population genomics studies, the increasing utilization of advanced bioinformatics platforms, a growing integration of GWAS in drug discovery, the expansion of personalized medicine research programs, and an enhanced focus on disease risk prediction.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Genome-Wide Association Studies Market Growth?
A rising need for personalized medicine is projected to fuel the expansion of the genome-wide association studies market in the future. This medical approach involves customizing treatment and prevention methods based on an individual’s specific genetic profile, way of life, and surroundings. The growing acceptance of personalized medicine stems largely from progress in genomics, allowing for the accurate detection of genetic differences and individualized therapeutic interventions. Genome-wide association studies (GWAS) improve personalized medicine by pinpointing genetic variations associated with illnesses, thus facilitating specific treatment plans. These studies contribute to better healthcare results by offering understanding of individual risk factors and backing precise treatments. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, which was a notable rise from the 12 approved in 2022. Consequently, the rising demand for personalized medicine is a key impetus for the expansion of the genome-wide association studies market.
How Is The Genome-Wide Association Studies Market Categorized Across Its Segment Groups?
The genome-wide association studies market covered in this report is segmented –
1) By Product Type: Genotyping Services, Genotyping Kits And Reagents, Software And Data Analysis Tools, Other Product Types
2) By Application: Drug Discovery, Disease Risk Assessment, Personalized Medicine, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Clinics, Other End-Users
Subsegments:
1) By Genotyping Services: Whole Genome Sequencing (Wgs), Exome Sequencing, Targeted Genotyping
2) By Genotyping Kits And Reagents: Dna Extraction Kits, Sequencing Reagents, Library Preparation Kits
3) By Software And Data Analysis Tools: Bioinformatics Platforms, Data Visualization Tools, Statistical Analysis Software
4) By Other Product Types: Sample Collection Devices, Quality Control Tools, Laboratory Consumables
Which Trends Are Shaping Growth In The Genome-Wide Association Studies Market?
Leading companies active in the genome-wide association studies market are focusing on developing innovative solutions, such as sophisticated research platforms to accelerate disease discovery and personalized medicine applications. An advanced research platform is an integrated system of tools and technologies that enables large-scale genomic data generation, analysis, and interpretation for genome-wide association studies. For instance, in January 2025, 23andMe Holding Co., a US-based biotechnology company, launched Discover23, a consumer-focused platform for genetic insights and ancestry exploration. It enables biopharma collaborators to access comprehensive genetic data through a trusted environment powered by Lifebit. It provides analysis-ready genome-wide association studies (GWAS) on over 1,000 disease cohorts, derived from billions of phenotypic data points from millions of consenting participants. The advanced research platform aims to accelerate drug discovery by helping researchers identify novel disease biology and potential drug targets and improve clinical trial success while maintaining participant privacy.
Which Firms Are Influencing Competition In The Genome-Wide Association Studies Market?
Major companies operating in the genome-wide association studies market are F. Hoffmann-La Roche AG, AstraZeneca plc, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Laboratory Corporation of America Holdings, Daiichi Sankyo Company Limited, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Databricks Inc., Broad Institute of MIT and Harvard, BGI Genomics Co. Ltd., deCODE genetics Inc., Genomics England Ltd., CD Genomics Inc., Veritas Genetics Inc., Finngen, The Wellcome Sanger Institute
Get The Full Genome-Wide Association Studies Market Report:
Which Region Dominates The Genome-Wide Association Studies Market By Market Share?
North America was the largest region in the genome-wide association studies market in 2025. The regions covered in the genome-wide association studies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Genome-Wide Association Studies Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Genome-Wide Association Studies Market 2026, By The Business Research Company
Consumer Genomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report
Genomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report
Genomics Personalized Health Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model